Dr. Roger Packer, MD
Claim this profileChildren's National Medical Center
Area of expertise
Brain Tumor
Roger Packer, MD has run 8 trials for Brain Tumor. Some of their research focus areas include:
Diffuse Intrinsic Pontine Glioma
Roger Packer, MD has run 4 trials for Diffuse Intrinsic Pontine Glioma. Some of their research focus areas include:
Affiliated Hospitals
Children's National Medical Center
Children's National Hospital
Clinical Trials Roger Packer, MD is currently running
ExAblate 4000 System
for Brain Tumor
The goal of this prospective, non-randomized, single-arm, feasibility study is to develop data to evaluate the safety and feasibility of ExAblate 4000 treatment of benign intracranial tumors which require clinical intervention in pediatric and young adult subjects. Indication of Use: Ablation of benign intracranial tumors in children and young adults which are ExAblate accessible.
Recruiting
1 award
N/A
Individualized Treatment
for Medulloblastoma
The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility in the pilot phase of performing real-time drug screening on tissue taken during surgery in patients with relapsed medulloblastoma or ependymoma and of having a specialized tumor board assign a treatment plan based on the results of this screening and genomic sequencing. The aim of this trial is to allow every child and young adult with relapsed medulloblastoma and ependymoma to receive the most effective and least toxic therapies currently available and will pave the way for improved understanding and treatment of these tumors in the future. Moreover, if successful, it could serve as a paradigm for personalized medicine programs for other types of cancer.
Recruiting
1 award
N/A
More about Roger Packer, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Roger Packer, MD has experience with
- INCB7839
- Doxorubicin
- Exablate
- ExAblate 4000 System
- Nivolumab
- K27M Peptide
Breakdown of trials Roger Packer, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Neurofibromatosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roger Packer, MD specialize in?
Roger Packer, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are H3F3A.
Is Roger Packer, MD currently recruiting for clinical trials?
Yes, Roger Packer, MD is currently recruiting for 4 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Roger Packer, MD has studied deeply?
Yes, Roger Packer, MD has studied treatments such as INCB7839, Doxorubicin, Exablate.
What is the best way to schedule an appointment with Roger Packer, MD?
Apply for one of the trials that Roger Packer, MD is conducting.
What is the office address of Roger Packer, MD?
The office of Roger Packer, MD is located at: Children's National Medical Center, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.